.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Queensland Health
Federal Trade Commission
Deloitte
AstraZeneca
Fish and Richardson
Colorcon
Baxter
Healthtrust
Teva

Generated: September 24, 2017

DrugPatentWatch Database Preview

Details for Patent: ► Subscribe

« Back to Dashboard

Summary for Patent: ► Subscribe

Title: Diltiazem formulation
Abstract:The present invention is directed to a diltiazem formulation suitable for one a day administration. The formulation contains a blend of diltiazem beads having two differing dissolution profiles.
Inventor(s): Hendrickson; Dennis L. (Overland Park, KS), Dimmitt; Dan C. (Belton, MO), Williams; Mark S. (Kansas City, MO), Skultety; Paul F. (Leawood, KS), Baltezor; Michael J. (Lees Summit, MO)
Assignee: Carderm Capital L.P. (Thalwil, CH)
Application Number:08/058,534
Patent Claim Types:
see list of patent claims
Formulation; Dosage form; Composition; Device;

No matches for this query

International Patent Family for Patent: ► Subscribe

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Germany69216910► Subscribe
Denmark0514814► Subscribe
European Patent Office0514814► Subscribe
Spain2099764► Subscribe
Finland922270► Subscribe
Greece3022927► Subscribe
Canada2068980► Subscribe
Ireland921603► Subscribe
Australia653223► Subscribe
Australia1632692► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Healthtrust
AstraZeneca
Fuji
Fish and Richardson
Baxter
QuintilesIMS
Johnson and Johnson
Moodys
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot